2/25
06:24 am
prax
Praxis Precision Medicines (PRAX) was upgraded by Wolfe Research to "strong-buy".
Low
Report
Praxis Precision Medicines (PRAX) was upgraded by Wolfe Research to "strong-buy".
2/25
06:24 am
prax
Praxis Precision Medicines (PRAX) was upgraded by Wolfe Research to "strong-buy".
Low
Report
Praxis Precision Medicines (PRAX) was upgraded by Wolfe Research to "strong-buy".
2/24
07:15 am
prax
Rating for PRAX
Low
Report
Rating for PRAX
2/24
07:15 am
prax
Rating for PRAX
Low
Report
Rating for PRAX
2/23
06:01 pm
prax
Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
2/23
06:01 pm
prax
Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Wolfe Research. They set an "outperform" rating on the stock.
2/23
04:15 pm
prax
Praxis Precision initiated with an Outperform at Wolfe Research
Low
Report
Praxis Precision initiated with an Outperform at Wolfe Research
2/23
04:15 pm
prax
Praxis Precision initiated with an Outperform at Wolfe Research
Low
Report
Praxis Precision initiated with an Outperform at Wolfe Research
2/20
12:55 pm
prax
Rating for PRAX
Low
Report
Rating for PRAX
2/20
12:55 pm
prax
Rating for PRAX
Low
Report
Rating for PRAX
2/20
12:00 pm
prax
Rating for PRAX
Low
Report
Rating for PRAX
2/20
12:00 pm
prax
Rating for PRAX
Low
Report
Rating for PRAX
2/20
08:23 am
prax
Rating for PRAX
Low
Report
Rating for PRAX
2/20
08:23 am
prax
Rating for PRAX
Low
Report
Rating for PRAX
2/10
09:07 am
prax
Rating for PRAX
Low
Report
Rating for PRAX
2/10
09:07 am
prax
Rating for PRAX
Low
Report
Rating for PRAX
2/10
07:14 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Guggenheim.
2/10
07:14 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Guggenheim.
2/4
06:26 am
prax
Rating for PRAX
Medium
Report
Rating for PRAX
2/4
06:26 am
prax
Rating for PRAX
Medium
Report
Rating for PRAX
2/2
09:44 am
prax
Rating for PRAX
Low
Report
Rating for PRAX
2/2
09:44 am
prax
Rating for PRAX
Low
Report
Rating for PRAX
2/2
07:00 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $282.00 price target on the stock.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Wells Fargo & Company. They set an "equal weight" rating and a $282.00 price target on the stock.
2/2
06:00 am
prax
Praxis Precision initiated with an Equal Weight at Wells Fargo
Low
Report
Praxis Precision initiated with an Equal Weight at Wells Fargo
2/2
06:00 am
prax
Praxis Precision initiated with an Equal Weight at Wells Fargo
Low
Report
Praxis Precision initiated with an Equal Weight at Wells Fargo